ASXSubmission of the Third PMA Module to the US FDA for Review
other announcement
IMRICOR MED SYS CDI1:1 USPROHEXCLQIB (IMR) News
Latest articles and price-sensitive announcements with AI sentiment classification.
Granting of ASX Waiver - US Financial Reporting Requirements
other announcement
Update - Notification regarding unquoted securities - IMR
other announcement
Imricor Completes Successful A$60 Million Capital Raise
other announcement
Imricor Q1 CY26 Quarterly Activities Report and Appendix 4C
other announcement
Small CapsImricor Submits NorthStar for U.S. Pediatric Expansion
other announcement
Notice of Annual Stockholders Meeting and CDI Voting Form
other announcement
Imricor Submits Advantage-MR System for FDA 510(K) Clearance
other announcement
Oklahoma Heart Institute to Become 4th US VISABL-AFL Site
other announcement
Imricor Q4 CY25 Quarterly Activities Report and Appendix 4C
other announcement
VCU Health to Become Third U.S. Site for VISABL-AFL
other announcement
UVA Health to Become Second U.S. Site for VISABL-AFL
other announcement
First in Human Ischemic VT Ablation Performed in iCMR
other announcement
Imricor Q3 CY25 Quarterly Activities Report and Appendix 4C
other announcement
Canaccord Drug & Device Conference Noosa 2025 Presentation
other announcement
Imricor Performs World's First PFA Ablation in the iCMR
other announcement